As of 2025-07-20, the EV/EBITDA ratio of FUREN Group Pharmaceutical Co Ltd (600781.SS) is -2.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 600781.SS's latest enterprise value is 4,850.13 mil CNY. 600781.SS's TTM EBITDA according to its financial statements is -2,112.76 mil CNY. Dividing these 2 quantities gives us the above 600781.SS EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.0x - 20.2x | 17.4x |
| Forward P/E multiples | 7.2x - 10.8x | 9.8x |
| Fair Price | (44.15) - (43.28) | (52.78) |
| Upside | -5834.4% - -5720.6% | -6954.4% |
| Date | EV/EBITDA |